Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

Abstract excerpt

Myasthenia gravis (MG) is an autoimmune disease caused by antibodies which attack receptors at the neuromuscular junction. One of the main difficulties in predicting the clinical course of MG is the heterogeneity of the disease, where disease progression differs greatly depending on the subgroup that the patient is classified into. MG subgroups are classified according to: age of onset [early onset MG (EOMG;...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Myasthenia Gravis and Thymoma
• Share to Thyroid and Parathyroid Surgery